Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis
β Scribed by Reis-Filho, Jorge S; Savage, Kay; Lambros, Maryou B K; James, Michelle; Steele, Dawn; Jones, Robin L; Dowsett, Mitch
- Book ID
- 109888444
- Publisher
- Nature Publishing Group
- Year
- 2006
- Tongue
- English
- Weight
- 333 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0893-3952
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cyclin D1 (CCND1) amplification is found in 10-15 per cent of invasive breast carcinomas, but it is not well established whether this gene alteration also occurs in the precursor of invasive breast carcinoma, ductal carcinoma in situ (DCIS). By Southern blot analysis, cyclin D1 gene amplification wa
p21 WAF1/Cip1 is an inhibitor of cdk/cyclin complexes, and thus regulates the cell cycle. p21 is also related to cell differentiation and is regulated by wild-type p53, although p53-independent regulatory pathways have been proposed. In order to analyse p21 expression as well as its relationship wit
Cyclin D1 is a major positive regulator of the G 1 restriction point promoting inactivation of the retinoblastoma protein (RB). The cyclin D1 gene is rearranged, amplified and/or over-expressed in several human neoplasms. In the present series of 64 human breast carcinomas, cyclin D1 amplification (